SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

AstraZeneca Hypertension Drug Recommended for EU Approval

The European Medicines Agency's human-medicines committee recommended AstraZeneca's Baxfendy for approval to treat insufficiently controlled hypertension.

AZN
SquawkNews Desk 1 updates Updated Nov 13, 2026, 11:47 AM UTC

Story updates

11:47:11 AM UTC
SquawkNews
... AstraZeneca Based on Phase III results showing statistically significant and clinically meaningf

Related stories

Merck Combination Wins EU Panel Backing for Advanced Kidney Cancer An EU panel backed Merck’s Welireg-lenvatinib combination for advanced kidney cancer. M impact | REGULATION | Nov 13, 2026, 11:35 AM UTC CHMP Recommends EU Approval of Roche’s Gazyva for Lupus The European Medicines Agency’s CHMP recommended EU approval of Roche’s Gazyva/Gazyvaro for systemic lupus erythematosus (SLE). M impact | REGULATION | Nov 13, 2026, 11:30 AM UTC Irish regulator fines Tinder owner €11 million Ireland's data protection regulator fined the owner of Tinder €11 million. M impact | REGULATION | Nov 13, 2026, 11:27 AM UTC EMA Committee Recommends Indication Extensions for Bexsero and Talzenna The EMA's CHMP recommended extensions of indication for Bexsero and Talzenna. M impact | REGULATION | Nov 13, 2026, 11:16 AM UTC EMA Committee Recommends Steglatro Indication Extension The EMA’s CHMP recommends extending Steglatro’s therapeutic indication. L impact | REGULATION | Nov 13, 2026, 11:07 AM UTC Megaspeed Unit Under Probe in Malaysia Over AI Chip Re-exports M impact | REGULATION | Nov 13, 2026, 11:02 AM UTC